Universität zu Köln

Journal Article

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Diehl, Volker, Cerny, Thomas, Markova, Jana, Ho, Anthony D., Eich, Hans-Theodor, Mueller-Hermelink, Hans Konrad, Kanz, Lothar, Greil, Richard, Rank, Andreas, Paulus, Ursula, Smardova, Lenka, Huber, Christoph, Doerken, Bernd, Nerl, Christoph, Krause, Stefan W., Mueller, Rolf-Peter, Fuchs, Michael and Engert, Andreas (2011). Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group. J. Clin. Oncol., 29 (32). S. 4234 - 4243. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 0732-183X

Eich, Hans Theodor, Diehl, Volker, Goergen, Helen, Pabst, Thomas, Markova, Jana, Debus, Juergen, Ho, Anthony, Doerken, Bernd, Rank, Andreas, Grosu, Anca-Ligia, Wiegel, Thomas, Karstens, Johann Hinrich, Greil, Richard, Willich, Normann, Schmidberger, Heinz, Doehner, Hartmut, Borchmann, Peter, Mueller-Hermelink, Hans-Konrad, Mueller, Rolf-Peter and Engert, Andreas (2010). Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial. J. Clin. Oncol., 28 (27). S. 4199 - 4207. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Sinn, Marianne, Bahra, Marcus, Liersch, Torsten, Gellert, Klaus, Messmann, Helmut, Bechstein, Wolf ORCID: 0000-0002-3267-8145, Waldschmidt, Dirk, Jacobasch, Lutz, Wilhelm, Martin, Rau, Bettina M., Gruetzmann, Robert, Weinmann, Arndt ORCID: 0000-0003-1198-1716, Maschmeyer, Georg, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Stieler, Jens M., Striefler, Jana K., Ghadimi, Michael, Bischoff, Sven, Doerken, Bernd, Oettle, Helmut and Riess, Hanno (2017). CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial. J. Clin. Oncol., 35 (29). S. 3330 - 3341. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Ullrich, Katrin, Wurster, Kathrin D., Lamprecht, Bjoern, Koechert, Karl, Engert, Andreas, Doerken, Bernd, Janz, Martin ORCID: 0000-0002-1127-0044 and Mathas, Stephan (2011). BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines. Br. J. Haematol., 155 (3). S. 398 - 404. HOBOKEN: WILEY. ISSN 1365-2141

Yu, Yong, Schleich, Kolja, Yue, Bin, Ji, Sujuan, Lohneis, Philipp, Kemper, Kristel, Silvis, Mark S., Qutob, Nouar, van Rooijen, Ellen, Werner-Klein, Melanie, Li, Lianjie, Dhawan, Dhriti, Meierjohann, Svenja, Reimann, Maurice, Elkahloun, Abdel, Treitschke, Steffi, Doerken, Bernd, Speck, Christian, Mallette, Frederick A. ORCID: 0000-0001-7932-0338, Zon, Leonard I., Holmen, Sheri L., Peeper, Daniel S., Samuels, Yardena ORCID: 0000-0002-3349-7266, Schmitt, Clemens A. ORCID: 0000-0002-4731-2226 and Lee, Soyoung ORCID: 0000-0002-4614-2931 (2018). Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma. Cancer Cell, 33 (2). S. 322 - 345. CAMBRIDGE: CELL PRESS. ISSN 1878-3686